Glutamine dipeptide supplementation improves clinical responses in patients with diabetic foot syndrome

The effect of glutamine dipeptide (GDP) supplementation in patients with diabetic foot syndrome was evaluated. A total of 22 patients took part in the study. GDP was supplied in 10 g sachets, and was dissolved in water immediately before use, with ingestion once a day, after lunch or after dinner (20 g/day) over a period of 30 days. Quantification of foot insensitive areas, oxidative stress, blood cytokines, and biochemical, hematological and toxicological parameters was performed before and after GDP supplementation. We observed an increase in blood levels of interferon-α (P=0.023), interferon-γ (P=0.038), interleukin-4 (P=0.003), interleukin-6 (P=0.0025), interleukin-7 (P=0.028), interleukin-12 p40 (P=0.017), interleukin-13 (P=0.001), leukocytes (P=0.037), eosinophils (P=0.049), and typical lymphocytes (

Capacidade antioxidante na Hb S: influência de talassemia alfa, haplótipos do gene βS globina e melatonina

A anemia falciforme (Hb SS), caracterizada por estados de inflamação crônica e eventos de agressão isquêmica e reperfusão pode causar danos oxidativos às macromoléculas biológicas. Os genes epistáticos e os haplótipos do gene da globina βS são possíveis moduladores de variabilidade fenotípica na Hb SS. A melatonina pode atenuar o estresse oxidativo e abrandar a morbidade. O objetivo deste foi analisar a influência de talassemia alfa (-α3.7), haplótipos do gene βS e melatonina na capacidade antioxidante total e expressão fenotípica, em indivíduos com Hb SS e Hb AS. Para avaliar o nível de melatonina sérica foram selecionadas 15 amostras de pacientes com Hb SS e 24 com Hb AA da região noroeste do estado do Paraná (NOPR). A triagem das hemoglobinas foram realizadas por métodos eletroforéticos e cromatográfico, e a caracterização genotípica da Hb S por meio de PCR- RFLP e PCR-AE. As espécies reativas de ácido tiobarbitúrico (TBARS), e a capacidade antioxidante total em equivalência ao Trolox (TEAC) foram determinadas por meio da espectrofotometria. A melatonina foi estimada por meio de HPLC. O estado redox foi analisado selecionando amostras de 68 indivíduos com Hb SS, 53 com Hb AS e 149 com Hb AA, das regiões sul e sudeste do Brasil. Para analisar a influência dos genes epistáticos sobre a TEAC, melatonina e expressão fenotípica, foram selecionadas 17 amostras com Hb SS, 30 com Hb AS, e 30 com Hb AA, da NOPR. O critério para elegebilidade foi ser não fumantes não gestantes, não etilistas e estar na fase estável para os indivíduos com HbSS. Os haplótipos do gene βS e a talassemia -α3.7 foram identificados por meio de PCR-RFLP e PCR multiplex, respectivamente. Os níveis séricos de melatonina apresentaram-se reduzidos nos indivíduos com Hb SS (P<0,001), e os TBARS e TEAC elevados quando comparados a grupo controle (P<0,001 e P<0,01 respectivamente)...Sickle cell disease (Hb SS), characterized by chronic inflammation and ischemic damage episodes and reperfusion, comprises excessive production of free radicals which can cause oxidative damage to biologic macromolecules. The epistatic genes and the polymorphism of the βS globin gene region are possible modulators of phenotypical variability of sickle cell disease in Hb SS. Melatonin can diminish both the oxidative stress and morbidity. The objective of this study was to analyze the influence of -α-3.7 thalassemia and from βS gene haplotypes on total anti-oxidant capacity, melatonin serum levels and phenotypical expression in individuals with Hb SS and Hb AS. To evaluate melatonin serum level 15 samples with HbSS and 24 with Hb AA from the northwest region of Paraná state (NOPR). The hemoglobin screenings were performed by electrophoretic and chromatographic methods and genotypic characterization of Hb S by PCR- RFLP and PCR-AE. The concentrations of thiobarbituric acid reactive substances (TBARS), used as markers of oxidative stress and total antioxidant capacity in equivalence to Trolox (TEAC), were determined by spectrophotometry. Melatonin was estimated by HPLC. The redox state was analyzed through selecting 68 individuals with Hb SS, 53 with Hb AS and 149 with Hb AA from Brazil’s south and southeast regions. To analyze the influence of epistatic genes on TEAC, melatonin and phenotypical expression, there were selected 17 samples with Hb SS, 30 with Hb AS, and 30 with Hb AA from NOPR. The βS gene haplotypes and -α-3.7 thalassemia were identified through RFLP-PCR and multiplex PCR, respectively. The melatonin serum levels appeared significantly reduced in individuals with Hb SS (P<0.001); and the TBARS and TEAC appeared significantly increased when compared to the control group (P<0.001 and P<0.01, respectively). The correlation between TBARS and TEAC (r=0.51; P=0.04)... (Complete abstract click electronic access below

Glutamine dipeptide supplementation improves clinical responses in patients with diabetic foot syndrome

ABSTRACT The effect of glutamine dipeptide (GDP) supplementation in patients with diabetic foot syndrome was evaluated. A total of 22 patients took part in the study. GDP was supplied in 10 g sachets, and was dissolved in water immediately before use, with ingestion once a day, after lunch or after dinner (20 g/day) over a period of 30 days. Quantification of foot insensitive areas, oxidative stress, blood cytokines, and biochemical, hematological and toxicological parameters was performed before and after GDP supplementation. We observed an increase in blood levels of interferon-&#945; (P=0.023), interferon-&#947; (P=0.038), interleukin-4 (P=0.003), interleukin-6 (P=0.0025), interleukin-7 (P=0.028), interleukin-12 p40 (P=0.017), interleukin-13 (P=0.001), leukocytes (P=0.037), eosinophils (P=0.049), and typical lymphocytes (P<0.001) due to GDP administration. In addition, we observed a reduced number (P=0.048) of insensitive areas on the foot, and reduction (P=0.047) of fasting hyperglycemia. Patients also showed increased blood high density lipoprotein (P<0.01) and protein thiol groups (P=0.004). These favorable results were associated with the absence of renal and hepatic toxicity. These results are of clinical relevance, since supplementation with GDP over 30 days improved clinical responses in patients with diabetic foot syndrome

Interaction between Hb SS and alpha thalassemia (3.7 kb deletion): a familial study

Submitted by Guilherme Lemeszenski ([email protected]) on 2013-08-22T18:40:41Z No. of bitstreams: 1 S1516-84842011000300021.pdf: 154640 bytes, checksum: 353fe6c9e58df755e1f761486841059f (MD5)Made available in DSpace on 2013-08-22T18:40:41Z (GMT). No. of bitstreams: 1 S1516-84842011000300021.pdf: 154640 bytes, checksum: 353fe6c9e58df755e1f761486841059f (MD5) Previous issue date: 2011-06-01Made available in DSpace on 2013-09-30T19:26:38Z (GMT). No. of bitstreams: 2 S1516-84842011000300021.pdf: 154640 bytes, checksum: 353fe6c9e58df755e1f761486841059f (MD5) S1516-84842011000300021.pdf.txt: 9624 bytes, checksum: 4513f29ea6ba7cb3aada991f2f106486 (MD5) Previous issue date: 2011-06-01Submitted by Vitor Silverio Rodrigues ([email protected]) on 2014-05-20T14:00:35Z No. of bitstreams: 2 S1516-84842011000300021.pdf: 154640 bytes, checksum: 353fe6c9e58df755e1f761486841059f (MD5) S1516-84842011000300021.pdf.txt: 9624 bytes, checksum: 4513f29ea6ba7cb3aada991f2f106486 (MD5)Made available in DSpace on 2014-05-20T14:00:35Z (GMT). No. of bitstreams: 2 S1516-84842011000300021.pdf: 154640 bytes, checksum: 353fe6c9e58df755e1f761486841059f (MD5) S1516-84842011000300021.pdf.txt: 9624 bytes, checksum: 4513f29ea6ba7cb3aada991f2f106486 (MD5) Previous issue date: 2011-06-01Universidade Estadual Paulista Julio de Mesquita Filho Biology Department Laboratório de Hemoglobinas e Genética de Doenças HematológicasUniversidade Estadual Paulista Julio de Mesquita Filho Biology Department Laboratório de Hemoglobinas e Genética de Doenças Hematológica

Serum melatonin level and oxidative stress in sickle cell anemia

This study evaluated serum melatonin levels in patients with sickle cell anemia (SCA) and compared the results to lipid peroxidation by determining thiobarbituric acid-reactive substances (TBARS) and Trolox equivalent antioxidant capacity (TEAC). The group studied was composed of 15 SCA patients and 24 subjects without hemoglobinopathies. The average melatonin level was significantly reduced in the SCA patients (p<0.001) when compared to the control group. The SCA patients showed significantly higher values for TBARS and TEAC when compared to values obtained for the control group (p<0.001 and p<0.01). Results from the correlation analysis in the SCA group were not statistically significant for any parameters except for TBARS and TEAC levels, which had a positive correlation (r = 0.51; p = 0.04), suggesting the participation of melatonin in antioxidant defense. The use of melatonin could be a possible therapeutic target for improving antioxidant defense and to reduce oxidative damage, alleviating symptoms associated with SCA. (C) 2010 Elsevier B.V. All rights reserved.Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP

Glutamine dipeptide supplementation improves clinical responses in patients with diabetic foot syndrome

ABSTRACT The effect of glutamine dipeptide (GDP) supplementation in patients with diabetic foot syndrome was evaluated. A total of 22 patients took part in the study. GDP was supplied in 10 g sachets, and was dissolved in water immediately before use, with ingestion once a day, after lunch or after dinner (20 g/day) over a period of 30 days. Quantification of foot insensitive areas, oxidative stress, blood cytokines, and biochemical, hematological and toxicological parameters was performed before and after GDP supplementation. We observed an increase in blood levels of interferon-α (P=0.023), interferon-γ (P=0.038), interleukin-4 (P=0.003), interleukin-6 (P=0.0025), interleukin-7 (P=0.028), interleukin-12 p40 (P=0.017), interleukin-13 (P=0.001), leukocytes (P=0.037), eosinophils (P=0.049), and typical lymphocytes (P<0.001) due to GDP administration. In addition, we observed a reduced number (P=0.048) of insensitive areas on the foot, and reduction (P=0.047) of fasting hyperglycemia. Patients also showed increased blood high density lipoprotein (P<0.01) and protein thiol groups (P=0.004). These favorable results were associated with the absence of renal and hepatic toxicity. These results are of clinical relevance, since supplementation with GDP over 30 days improved clinical responses in patients with diabetic foot syndrome